Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025

Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025#Nxera #Pharma #Notes #Neurocrine #Biosciences #Presents #Positive #Data #Phase #Study #NBI1117568 #Adults #Schizophrenia #American #Society #Clinical #Psychopharmacology